Advanced Search

Revenue Cycle Insider

Otolaryngology Coding:

Get Up to Speed With Drug-Eluting Sinus Implant Coding

Published on Fri Dec 26, 2025

Use this handy decision tree for accurate billing documentation. Drug-eluting sinus implants, such as Propel and Sinuva, are vital tools in managing chronic rhinosinusitis and recurrent nasal polyps, especially in postoperative treatment plans after endoscopic sinus surgery (ESS). Historically, both implants were classified under a single HCPCS Level II code; however, on April 1, 2021, the single code was replaced [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles of

December 2025

View All